SCHEMBL124830

SCHEMBL124830

CC[N+](CC)(CC)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
CHRNB4 P30926 5/20 0.41
CHRNA3 P32297 5/20 0.41
CHRNA7 P36544 5/20 0.41
CHRNB2 P17787 3/20 0.41
CHRNA4 P43681 3/20 0.41
TP53 P04637 1/20 0.41
ACHE P22303 3/20 0.37
TSHR P16473 1/20 0.37
OPRM1 P35372 1/20 0.37
CHRM4 P08173 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
BLM P54132 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27833063 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
Ammonia Solution, Strong SCHEMBL27375432 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
Iodide SCHEMBL2353165 0.97 APOBEC3A (0.50) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
Bromide SCHEMBL5088443 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
Bromide SCHEMBL2708615 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
Hydrochloric Acid SCHEMBL125419 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
Bromide SCHEMBL2708617 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
Water SCHEMBL188046 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
SCHEMBL9752206 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7
SCHEMBL28320297 0.97 APOBEC3A (0.43) APOBEC3AAPOBEC3GCHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174523-A1 SYNTHESIS OF ZEOLITIC MATERIAL HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF CORPORATION 2024-05-30 US claimed
EP-4313864-A1 SYNTHESIS OF ZEOLITIC MATERIALS HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF Corporation (US) 2024-02-07 EP claimed
CN-117062777-A Synthesis of zeolite material having AFT framework structure and SCR catalyst comprising the same 巴斯夫公司 2023-11-14 CN claimed
EP-3548581-B1 COMPOSITION FOR REMEDIATING IRON SULFIDE IN OILFIELD PRODUCTION SYSTEMS CHAMPIONX USA INC (US) 2023-09-06 EP claimed
EP-4208500-A1 POLYMERS CONTAINING REPEATING UNITS WITH SEVERAL METAL OR ORGANIC SULPHONATE UNITS, METHODS FOR PREPARING SAME AND USES THEREOF CDP-Innovation (FR) 2023-07-12 EP claimed
CN-116323694-A Bis (heterocyclic-alkoxide) lewis base catalysts and methods thereof 埃克森美孚化学专利公司 2023-06-23 CN claimed
US-11597868-B2 Composition for remediating iron sulfide in oilfield production systems CHAMPIONX USA INC. (US) 2023-03-07 US claimed
CN-115362187-A Polyethylene compositions obtained using transition metal bis (phenolate) catalyst complexes and homogeneous processes for producing the same 埃克森美孚化学专利公司 2022-11-18 CN claimed
WO-2022199574-A1 SYNTHESIS OF ZEOLITIC MATERIALS HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF CORPORATION (US) 2022-09-29 WO claimed
US-11419333-B2 Compositions and methods for biofilm removal CHAMPIONX USA INC. (US) 2022-08-23 US claimed
CN-1227835-A Process for preparing aldehydes CELANESE GMBH (DE) 1999-09-08 CN claimed
EP-0924182-A1 Process for the preparation of aldehydes Celanese GmbH (DE) 1999-06-23 EP claimed
EP-0924218-A1 Non aqueous ionogen liquid ligands, process for their preparation and their use as components for catalysts Celanese GmbH (DE) 1999-06-23 EP claimed
CN-1042330-C Process for producing phenyl propionic derivatives BOUCHARA SA (FR) 1999-03-03 CN claimed
US-4537843-A ELECTRODES OF POLYMER WITH CONJUGATED DOUBLE BONDS IN MAIN CHAIN, SHOWA DENKO KABUSHIKI KAISHA (JP) 1985-08-27 US claimed
EP-0141371-A1 Secondary Battery SHOWA DENKO KABUSHIKI KAISHA (JP) 1985-05-15 EP claimed
EP-0098006-A2 Isocyanurates and their preparation SOCIETE CARBOCHIMIQUE en abrégé "CARBOCHIM" (BE) 1984-01-11 EP claimed
EP-0098005-A2 1,3,5-Oxadiazine-2,4,6-trione salts, 1,3,5-oxadiazine-2,4,6-triones and their preparation SOCIETE CARBOCHIMIQUE en abrégé "CARBOCHIM" (BE) 1984-01-11 EP claimed
EP-0098004-A1 Salts of organic polyisocyanates and their preparation SOCIETE CARBOCHIMIQUE en abrégé "CARBOCHIM" (BE) 1984-01-11 EP claimed
US-4272435-A Process for the preparation of azo compounds from amino compounds in the presence of a phase transfer catalyst SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-06-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11419333-B2 Compositions and methods for biofilm removal ALG1, FUT5, FUT6 APOBEC3A 487/4885APOBEC3G 240/4885CHRNB4 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.